SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001651308-22-000089
Filing Date
2022-06-22
Accepted
2022-06-22 17:07:08
Documents
14
Period of Report
2022-06-21
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bgne-20220621.htm   iXBRL 8-K 126580
2 EX-10.1 ax22jun2022xex101xamendmen.htm EX-10.1 6438
3 EX-99.1 ax22jun2022xex991xtislechi.htm EX-99.1 21960
  Complete submission text file 0001651308-22-000089.txt   313891

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bgne-20220621.xsd EX-101.SCH 1984
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bgne-20220621_lab.xml EX-101.LAB 25070
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bgne-20220621_pre.xml EX-101.PRE 13105
8 EXTRACTED XBRL INSTANCE DOCUMENT bgne-20220621_htm.xml XML 11914
Mailing Address C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108
Business Address C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108 13459494123
BeiGene, Ltd. (Filer) CIK: 0001651308 (see all company filings)

IRS No.: 981209416 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37686 | Film No.: 221032790
SIC: 2834 Pharmaceutical Preparations